The consequences of chronic musculoskeletal pain (CMP) may extend well beyond physical discomfort, potentially leading to faster aging of the brain, new research showed. Using structural […]

A large study analyzing the DNA of children with cerebral palsy has found a high prevalence of genomic variation that likely contributes to the risk of […]

Multiple sclerosis (MS) has three distinct subtypes based on immune markers in patient’s blood, each with slightly different disease trajectories and responses to therapy, a new […]

The prevalence of dementia among homeless people is almost twice as high as that in housed populations in Ontario, Canada, according to the results of a […]

Amylyx Pharmaceuticals has announced plans to take sodium phenylbutyrate–taurursodiol (Relyvrio and Albrioza), its drugs for amyotrophic lateral sclerosis (ALS), off the market in the United States […]

Nontraditional risk factors such as migraine and autoimmune diseases have a significantly greater effect on stroke risk in young adults than traditional risk factors such as […]

Cognitive assessments administered via a smartphone app are a reliable and valid way to detect frontotemporal dementia (FTD) in high-risk individuals, new research showed. Cognitive tests […]